Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
järnhydroxidsackaroskomplex 100 mg/5 ml (Fe), intravenös vätska, lösning |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous phosphate (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järnnatriumkomplex av EDTA 190 mg/5 ml, elixir |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järn(II)sulfat 30 mg/5 ml, oral lösning för pediatriskt bruk |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järn(II)glycinsulfat, sirap |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järn(II)saltpreparat |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
natrium-järn(III)glukonatkomplex 12,5 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Iron dextran 100mg/2mL injection |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Iron dextran 50mg/mL injection |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järnsackaros 20 mg/ml, injektionsvätska, lösning, ampull 5 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Iron dextran 50mg/mL |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
folsyra 0,8 mg + järn 15 mg, droppar |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
folsyra + järn 1 mg/100 mg, vätska |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järndextrankomplex 50 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Polysaccharide-iron complex (substance) |
Is a |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous fumarate (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous sulfate (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Multivitamins+iron preparation |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Idiopathic hemochromatosis (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Bronze cirrhosis (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Bronze diabetes (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Primary hemochromatosis (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Hemochromatosis (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
järndextran 50 mg/ml, injektionsvätska, lösning, flaska 2 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järndextran 50 mg/ml, injektionsvätska, lösning, flaska 1 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järndextran 100 mg/2 ml, injektionsvätska, lösning, flaska 1 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järndextran 100 mg/2 ml, injektionsvätska, lösning, flaska 2 ml |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Adverse reaction to iron and iron compounds NOS |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
järn(II)glycinsulfat 562,5 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Ferrous sulfate 300 mg oral tablet |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
järn(II)fumarat + dokusatnatrium |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Infant formula + iron (product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
noretindron + etinylestradiol + järn(II)fumarat |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Percentage iron saturation |
Component |
False |
Iron |
Inferred relationship |
Some |
|
Unsaturated iron binding capacity measurement (procedure) |
Component |
True |
Iron |
Inferred relationship |
Some |
2 |
Total iron binding capacity measurement |
Component |
True |
Iron |
Inferred relationship |
Some |
1 |
Transferrin saturation index (procedure) |
Component |
True |
Iron |
Inferred relationship |
Some |
2 |
järndextrankomplex 100 mg/2 ml, injektionsvätska |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Plasma iron level (procedure) |
Component |
True |
Iron |
Inferred relationship |
Some |
2 |
Product containing ferrous fumarate and folic acid (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous gluconate and folic acid (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Product containing ferrous sulfate and folic acid (medicinal product) |
Has active ingredient |
False |
Iron |
Inferred relationship |
Some |
|
Corneal iron deposits (disorder) |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Fleisher ring |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Stocker's line |
Causative agent |
False |
Iron |
Inferred relationship |
Some |
|
Red cell iron utilization study |
Using substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
Radioiron oral absorption study |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
|
Red cell iron utilization study |
Using substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
Poisoning by iron |
Causative agent |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron peptonate (substance) |
Is a |
False |
Iron |
Inferred relationship |
Some |
|
Intermittent intravenous infusion of iron (procedure) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
2 |
Intravenous infusion of iron (procedure) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron modified diet (regime/therapy) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
1 |
Increased iron diet (regime/therapy) |
Direct substance |
False |
Iron |
Inferred relationship |
Some |
2 |
Decreased iron diet (regime/therapy) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron supplement therapy (regime/therapy) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
1 |
Sucroferric oxyhydroxide (substance) |
Is modification of (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Iron sucrose |
Is modification of (attribute) |
False |
Iron |
Inferred relationship |
Some |
|
Ferric ion |
Is a |
True |
Iron |
Inferred relationship |
Some |
|
Ferrous ion (substance) |
Is a |
True |
Iron |
Inferred relationship |
Some |
|
järn (som järnsorbitol) 100 mg/2 ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
järn (som järnsackaros) 50 mg/2,5 ml, injektionsvätska, lösning, flaska |
Has basis of strength substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
järn (som järnsackaros) 100 mg/5 ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
järn (som järndextran) 100 mg/2 ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Iron |
Inferred relationship |
Some |
1 |
Product containing only folic acid and iron (medicinal product) |
Has active ingredient |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing only iron (medicinal product) |
Has active ingredient |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron only product in oral dose form |
Has active ingredient |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing only iron in parenteral dose form (medicinal product form) |
Has active ingredient |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing precisely iron (as iron dextran) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron (as iron sucrose) 20 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Iron |
Inferred relationship |
Some |
1 |
Product containing precisely iron (as iron sorbitol) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iron |
Inferred relationship |
Some |
1 |
Corneal rust ring |
Causative agent |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron intake |
Process output |
True |
Iron |
Inferred relationship |
Some |
2 |
Estimated quantity of intake of iron in 24 hours (observable entity) |
Process output |
True |
Iron |
Inferred relationship |
Some |
6 |
Siderosis of eye |
Causative agent |
True |
Iron |
Inferred relationship |
Some |
1 |
Increased iron diet (regime/therapy) |
Direct substance |
True |
Iron |
Inferred relationship |
Some |
1 |
Measured quantity of intake of iron in 24 hours (observable entity) |
Process output |
True |
Iron |
Inferred relationship |
Some |
5 |
Product containing precisely iron (as ferric carboxymaltose) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iron |
Inferred relationship |
Some |
1 |
Iron adverse reaction |
Causative agent |
True |
Iron |
Inferred relationship |
Some |
1 |
Estimated required quantity of intake of iron in 24 hours |
Process output |
True |
Iron |
Inferred relationship |
Some |
4 |
Product containing precisely iron (as ferric derisomaltose) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Iron |
Inferred relationship |
Some |
1 |